| RQI | XLRE | RQI / XLRE | |
| Gain YTD | 0.941 | 2.727 | 35% |
| Net Assets | 1.68B | 7.46B | 23% |
| Total Expense Ratio | 2.21 | 0.08 | 2,763% |
| Turnover | 30.00 | 5.00 | 600% |
| Yield | 2.26 | 3.40 | 66% |
| Fund Existence | 24 years | 10 years | - |
| RQI | XLRE | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 87% | 2 days ago 86% |
| Momentum ODDS (%) | 2 days ago 80% | 2 days ago 83% |
| MACD ODDS (%) | 2 days ago 86% | 2 days ago 84% |
| TrendWeek ODDS (%) | 2 days ago 84% | 2 days ago 83% |
| TrendMonth ODDS (%) | 2 days ago 82% | 2 days ago 81% |
| Advances ODDS (%) | 9 days ago 89% | 20 days ago 87% |
| Declines ODDS (%) | 7 days ago 87% | 7 days ago 84% |
| BollingerBands ODDS (%) | 2 days ago 90% | N/A |
| Aroon ODDS (%) | 2 days ago 77% | N/A |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| USOI | 49.87 | 0.61 | +1.23% |
| UBS ETRACS Crude Oil Shares Cov Cll ETN | |||
| THNR | 25.22 | 0.23 | +0.94% |
| Amplify Weight Loss Drug & Treatment ETF | |||
| LCLG | 60.58 | N/A | N/A |
| Logan Capital Broad Innovative Gr ETF | |||
| LAPR | 25.16 | N/A | N/A |
| Innovator Premium Inc 15 Bffr ETF - Aprl | |||
| IPAC | 72.65 | -1.22 | -1.65% |
| iShares Core MSCI Pacific ETF | |||
A.I.dvisor tells us that RQI and O have been poorly correlated (+15% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RQI and O's prices will move in lockstep.